Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 3 results.

- Journal article
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial
Keating, S Suciu, Stefan[UCL] de Witte, T. Zittoun, R Mandelli, F. Belhabri, A Amadori, S. Fibbe, W Gallo, E Fillet, G. Varet, B. Meloni, G Hagemeijer, Anne[UCL] Fazi, P. Solbu, G Willemze, R. (2003) Leukemia — Vol. 17, no. 1, p. 60-67 (2003)
- Journal article
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA
Keating, S de Witte, T. Suciu, Stefan[UCL] Willemze, R. Hayat, M. Labar, B. Resegotti, L Ferrini, PR Caronia, F Dardenne, M Solbu, G Petti, MC Vegna, ML Mandelli, F. Zittoun, RA (1998) British Journal of Haematology — Vol. 102, no. 5, p. 1344-1353 (1998)
- Speech
Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study
Zittoun, R Suciu, Stefan[UCL] Solbu, G Watson, M. Muus, P. Mandelli, F. Stryckmans, P. Peetermans, M Thaler, J Willemze, R. (1995) —